2013•Journal of Chinese OncologyRequires access

Evaluation of Randomized Controlled Trials Reports on the Treatment for Tumor in CNKI Database

Lianming Liao

Open publisher page 0 citations

Abstract

[Purpose]To assess the quality of randomized controlled trials reports on the treatment for tumor in China. [Methods]All primary reports of randomized controlled trials for tumor treatment published in CNKI from 2006 to 2011 were enrolled. The quality of reporting was assessed according to consolidated standards of reporting trials statement in 2010.[Results]A total of 696 articles which met the inclusion criteria were analyzed. Reports with inclusion and exclusion criteria accounted for 82.04%. Reports describing randomization allocation method,blinding methods,random allocation concealment,baseline data,flow figure,sample size evaluation and trial registration accounted for 14.37%,0.43%,1.15%,1.87%,0.72%,0.29% and 0.14% of all reports respectively. [Conclusion]The quality of randomized controlled trials of cancer treatment is generally low,which needs to be further improved,especially the use of blinding and sample size calculation.

About this research paper

What this paper is about

[Purpose]To assess the quality of randomized controlled trials reports on the treatment for tumor in China. [Methods]All primary reports of randomized controlled trials for tumor treatment published in CNKI from 2006 to 2011 were enrolled. The quality of reporting was assessed according to consolidated standards of reporting trials statement in 2010.[Results]A total of 696 articles which met the inclusion criteria were analyzed. Reports with inclusion and exclusion criteria accounted for 82.04%. Reports describing randomization allocation method,blinding methods,random allocation concealment,baseline data,flow figure,sample size evaluation and trial registration accounted for 14.37%,0.43%,1.15%,1.87%,0.72%,0.29% and 0.14% of all reports respectively. [Conclusion]The quality of randomized controlled trials of cancer treatment is generally low,which needs to be further improved,especially the use of blinding and sample size calculation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Purpose]To assess the quality of randomized controlled trials reports on the treatment for tumor in China. [Methods]All primary reports of randomized controlled trials for tumor treatment published in CNKI from 2006 to 2011 were enrolled. The quality of reporting was assessed according to consolidated standards of reporting trials statement in 2010.[Results]A total of 696 articles which met the inclusion criteria were analyzed. Reports with inclusion and exclusion criteria accounted for 82.04%. Reports describing randomization allocation method,blinding methods,random allocation concealment,baseline data,flow figure,sample size evaluation and trial registration accounted for 14.37%,0.43%,1.15%,1.87%,0.72%,0.29% and 0.14% of all reports respectively. [Conclusion]The quality of randomized controlled trials of cancer treatment is generally low,which needs to be further improved,especially the use of blinding and sample size calculation.

Key concepts: Blinding, Medicine, Randomized controlled trial, Randomization, Sample size determination, Inclusion and exclusion criteria, Consolidated Standards of Reporting Trials, Clinical trial

Related papers

Back to paper searchBrowse research topicsOriginal source
Evaluation of Randomized Controlled Trials Reports on the Treatment for Tumor in CNKI Database — Research Paper | ScholarLens